FDA Commissioner Crawford: For Device Firms, His Reputation Precedes Him
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers are waiting to see whether FDA Commissioner-nominee Lester Crawford will be responsive to their concerns with the user fee program as he grapples with more high-profile food and drug safety issues
You may also be interested in...
Commissioner Nominee Crawford Must Answer “Tough Questions” – Grassley
Senate Finance Committee Chair Charles Grassley (R-Iowa) is noncommittal on FDA Acting Commissioner Lestor Crawford's nomination to fill the post on a permanent basis
Commissioner Nominee Crawford Must Answer “Tough Questions” – Grassley
Senate Finance Committee Chair Charles Grassley (R-Iowa) is noncommittal on FDA Acting Commissioner Lestor Crawford's nomination to fill the post on a permanent basis
FDA Commish Pick Imminent? Crawford Finally May Shed Understudy Role
The White House seems to have selected FDA Acting Commissioner Lester Crawford, PhD/DVM, as its choice to fill the commissioner slot on a permanent basis